Medovex Corporation's President and COO Patrick Kullmann to be Interviewed on the Georgia Business Radio
ATLANTA, GA -- (Marketwired) -- 08/13/15 -- Medovex Corp. (NASDAQ: MDVX), a developer of medical technology products, today announced that the Company's President and COO Patrick Kullmann will be a featured guest on Georgia Business Radio on Friday, August 14, 2015 at 10:00 am EDT.
The live segment may be listened to at the following link: http://buckhead.businessradiox.com/
Georgia Business Radio is hosted by Mr. Ryan McPherson, a graduate of the Connecticut School of Broadcasting and also a United States Army Veteran where he served as a Combat Infantryman and is a Purple Heart recipient.
Mr. McPherson retired from the Army in 2010. He ventured into the entrepreneurial world and became a small business leader and franchise owner/operator. He has conducted more than 200 interviews with business leaders from different industries and from varying levels of success. Both on the road and in the studio, his interviewing style is both engaging and conversational.
Medovex was formed to acquire and develop a diversified portfolio of potentially ground breaking medical technology products. Criteria for selection include those products with potential for significant improvement in the quality of patient care combined with cost effectiveness. The Company's first pipeline product, the DenerveX device, is intended to provide long lasting relief from pain associated with facet joint syndrome at significantly less cost than currently available options. DenerveX is not yet commercially available. To learn more about Medovex Corp., visit www.medovex.com
Safe Harbor Statement
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.
Source: Medovex Corporation
Released August 13, 2015